Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Details for Australian Patent Application No. 2011229164 (hide)

Owner Janssen Pharmaceuticals, Inc.

Inventors Ormerod, Dominic John; Depre, Dominique Paul Michel; Horvath, Andras

Agent Shelston IP

Pub. Number AU-A-2011229164

PCT Pub. Number WO2011/113859

Priority 10156681.8 16.03.10 EP

Filing date 16 March 2011

Wipo publication date 22 September 2011

International Classifications

C07C 51/487 Preparation of carboxylic acids or their salts, halides, or anhydrides

C07C 61/06 Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings

C07C 69/74 Esters of carboxylic acids

C07C 235/40 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/113859 Priority application(s): WO2011/113859

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011229173-Drug delivery device

2011229160-Drill bit